Maximum Retail Pricing Policy in the WHO South-East Asia Region

Overview

Access to essential medicines is a pressing issue in the WHO South-East Asia Region, where inadequate public health funding forces millions to bear high out-of-pocket costs, driving many into poverty.

The 2018 Delhi Declaration underscores the urgent need for affordable, effective, safe, and high-quality medicines to achieve universal health coverage and the 2030 Sustainable Development Goals.

This report delves into the region's regulatory frameworks and pricing policies, shedding light on the complexities and strategies involved in setting fair maximum retail prices for essential medicines.